Contribution of spinal glutamatergic mechanisms in heterosegmental antinociception induced by noxious stimulation

Pain

Volumn 106, Issue 1-2, 2003, Pages 173-179

  Tambeli, Claudia H ^a,b,c   Young, Andrew ^b   Levine, Jon D ^a,b   Gear, Robert W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Glutamate; NMDA and mGluR 5 receptors; Noxious stimulus induced antinociception

Indexed keywords

2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 CARBOXY 2 METHYLPHENYLGLYCINE; 6 METHYL 2 PHENYLAZO 3 PYRIDINOL; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR ANTAGONIST; CAPSAICIN; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 5 ANTAGONIST; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P; SUBSTANCE P RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DERMIS; DRUG EFFECT; DRUG SELECTIVITY; HINDLIMB; JAW OPENING REFLEX; MALE; MEASUREMENT; NERVE ENDING; NOCICEPTIVE RECEPTOR; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SENSORY NERVE; SPINAL NERVE;

EID: 0142227165     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00332-4     Document Type: Article

References (41)

1. Alvarez F.J., Villalba R.M., Carr P.A., Grandes P., Somohano P.M. Differential distribution of metabotropic glutamate receptors 1a, 1b, and 5 in the rat spinal cord. J Comp Neurol. 422:2000;464-487.
2. Banks D., Kuriakose M., Matthews B. Modulation by peripheral conditioning stimuli of the responses of trigeminal brain stem neurones and of the jaw opening reflex to tooth pulp stimulation in chronically prepared, anaesthetized cats. Exp Physiol. 77:1992;343-349.
3. Buelke-Sam J., Holson J.F., Bazare J.J., Young J.F. Comparative stability of physiological parameters during sustained anesthesia in rats. Lab Anim Sci. 28:1978;157-162.
4. Cao Y.Q., Mantyh P.W., Carlson E.J., Gillespie A.M., Epstein C.J., Basbaum A.I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 392:1998;390-394.
5. Cascieri M.A., Ber E., Fong T.M., Sadowski S., Bansal A., Swain C., Seward E., Frances B., Burns D., Strader C.D. Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor. Mol Pharmacol. 42:1992;458-463.
6. Chiang C.Y., Dostrovsky J.O., Sessle B.J. Periaqueductal gray matter and nucleus raphe magnus involvement in anterior pretectal nucleus-induced inhibition of jaw-opening reflex in rats. Brain Res. 544:1991;71-78.
7. Clark B.P., Baker S.R., Goldsworthy J., Harris J.R., Kingston A.E. (+)-2-Methyl-4-carboxyphenylgylcine (LY367385) selectively antagonises metabotropic glutamate mGlur1 receptors. Bioorg Med Chem Lett. 7:1997;2777-2780.
8. Davis A.M., Inturrisi C.E. Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist. Brain Res. 894:2001;150-153.
9. De Biasi S., Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci USA. 85:1988;7820-7824.
10. Dogrul A., Ossipov M.H., Lai J. Jr., Malan T.P., Porreca F. Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR(5)) antagonist, in experimental neuropathic pain in rats. Neurosci Lett. 292:2000;115-118.
11. Doubell T.P., Mannion R.J., Woolf C.J. The dorsal horn: state-dependent sensory processing, plasticity and the generation of pain. Wall P.D., Melzack R. Textbook of pain. 1999;165-181 Churchill Livingstone, Edinburgh.
12. Fisher K., Lefebvre C., Coderre T.J. Antinociceptive effects following intrathecal pretreatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain. Pharmacol Biochem Behav. 73:2002;411-418.
13. Gasparini F., Lingenhohl K., Stoehr N., Flor P.J., Heinrich M., Vranesic I., Biollaz M., Allgeier H., Heckendorn R., Urwyler S., Varney M.A., Johnson E.C., Hess S.D., Rao S.P., Sacaan A.I., Santori E.M., Velicelebi G., Kuhn R. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology. 38:1999;1493-1503.
14. Gear R.W., Aley K.O., Levine J.D. Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci. 19:1999;7175-7181.
15. Gear R.W., Levine J.D. Antinociception produced by an ascending spino-supraspinal pathway. J Neurosci. 15:1995;3154-3161.
16. Go V.L., Yaksh T.L. Release of substance P from the cat spinal cord. J Physiol (Lond). 391:1987;141-167.
17. Gottschalk A., Schroeder F., Ufer M., Oncu A., Buerkle H., Standl T. Amantadine, a N-methyl-D-aspartate receptor antagonist, does not enhance postoperative analgesia in women undergoing abdominal hysterectomy. Anesth Analg. 93:2001;192-196.
18. Henderson D.J., Withington B.S., Wilson J.A., Morrison L.M. Perioperative dextromethorphan reduces postoperative pain after hysterectomy. Anesth Analg. 89:1999;399-402.
19. Le Bars D., Dickenson A.H., Besson J.M. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain. 6:1979;283-304.
20. Le Bars D., Villanueva L., Bouhassira D., Willer J.C. Diffuse noxious inhibitory controls (DNIC) in animals and in man. Patol Fiziol Eksp Ter. 1992;55-65.
21. Lofgren O., Qi Y., Lundeberg T. Inhibitory effects of tachykinin receptor antagonists on thermally induced inflammatory reactions in a rat model. Burns. 25:1999;125-129.
22. Mason P., Strassman A., Maciewicz R. Is the jaw-opening reflex a valid model of pain? Brain Res. 357:1985;137-146.
23. Moochhala S.M., Sawynok J. Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization. Br J Pharmacol. 82:1984;381-388.
24. Movsesyan V.A., O'Leary D.M., Fan L., Bao W., Mullins P.G., Knoblach S.M., Faden A.I. mGluR5 antagonists 2-methyl-6-(phenylethynyl)-pyridine and (E)-2-methyl-6-(2-phenylethenyl)-pyridine reduce traumatic neuronal injury in vitro and in vivo by antagonizing N-methyl-D-aspartate receptors. J Pharmacol Exp Ther. 296:2001;41-47.
25. Nichols M.L., Allen B.J., Rogers S.D., Ghilardi J.R., Honore P., Luger N.M., Finke M.P., Li J., Lappi D.A., Simone D.A., Mantyh P.W. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science. 286:1999;1558-1561.
26. Ornstein P.L., Schoepp D.D., Arnold M.B., Augenstein N.K., Lodge D., Millar J.D., Chambers J., Campbell J., Paschal J.W., Zimmerman D.M., Leander J.D. 6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonists. J Med Chem. 35:1992;3547-3560.
27. Randle J.C., Guet T., Cordi A., Lepagnol J.M. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution. Eur J Pharmacol. 215:1992;237-244.
28. Schmidt B.L., Tambeli C.H., Barletta J., Luo L., Green P., Levine J.D., Gear R.W. Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine tolerant rats. J Neurosci. 22:2002;6773-6780.
29. Schmidt B.L., Tambeli C., Gear R.W., Levine J.D. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens. Neuroscience. 106:2001;129-136.
30. Schmidt B.L., Tambeli C.H., Levine J.D., Gear R.W. m/d Cooperativity and opposing k-opioid effects in nucleus accumbens-mediated antinociception in the rat. Eur J Neurosci. 15:2002;861-868.
31. Schoepp D.D., Ornstein P.L., Salhoff C.R., Leander J.D. Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist. J Neural Transm Gen Sect. 85:1991;131-143.
32. Sorkin L.S., McAdoo D.J. Amino acids and serotonin are released into the lumbar spinal cord of the anesthetized cat following intradermal capsaicin injections. Brain Res. 607:1993;89-98.
33. Tambeli C.H., Parada C.A., Levine J.D., Gear R.W. Inhibition of tonic spinal glutamatergic activity induces antinociception in the rat. Eur J Neurosci. 16:2002;1547-1553.
34. Todd A.J. Anatomy of primary afferents and projection neurones in the rat spinal dorsal horn with particular emphasis on substance P and the neurokinin 1 receptor. Exp Physiol. 87:2002;245-249.
35. Varney M.A., Cosford N.D., Jachec C., Rao S.P., Sacaan A., Lin F.F., Bleicher L., Santori E.M., Flor P.J., Allgeier H., Gasparini F., Kuhn R., Hess S.D., Velicelebi G., Johnson E.C. SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5. J Pharmacol Exp Ther. 290:1999;170-181.
36. Villanueva L., Le Bars D. The activation of bulbo-spinal controls by peripheral nociceptive inputs: diffuse noxious inhibitory controls. Biol Res. 28:1995;113-125.
37. Willis W.D., Coggeshall R.E. Structure of the dorsal horn, sensory mechanisms of the spinal cord. 1991;Plenum Press, New York. p. 79-148, Chapter 4.
38. Yaksh T.L., Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17:1976;1031-1036.
39. Zahn P.K., Umali E., Brennan T.J. Intrathecal non-NMDA excitatory amino acid receptor antagonists inhibit pain behaviors in a rat model of postoperative pain. Pain. 74:1998;213-223.
40. Zhang S., Tang J.S., Yuan B., Jia H. Electrically-evoked inhibitory effects of the nucleus submedius on the jaw-opening reflex are mediated by ventrolateral orbital cortex and periaqueductal gray matter in the rat. Neuroscience. 92:1999;867-875.
41. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.